Dive deep with Torrey Smith, Co-Founder & CEO of Endiatx, as he shares his groundbreaking journey in the world of medical technology. A fascinating look into the innovative use of drone technology within the field of gastroenterology.
Highlights:
▶ From Aerospace to medtech: Torrey Smith shares his journey from aerospace engineering to pioneering medical device technology. Inspired by his personal experiences and science fiction, Smith’s transition into medtech was driven by a desire to push the boundaries of what’s possible in healthcare.
▶ The Creation of PillBot™: The story behind the development of PillBot™ is as intriguing as a sci-fi movie. Smith discusses how this advanced prototype, resembling a tiny quadcopter, is designed to navigate the human stomach. This innovation represents a significant leap in GI tract examination and treatment.
▶ The Future of GI Robotics: Smith envisions the human stomach as the perfect starting point for deploying tiny robots in the human body. He explains how the stomach’s unique environment makes it an ideal playground for these swimming drones, potentially revolutionizing diagnostics and treatment in gastroenterology.
Torrey Smith’s innovative approach in blending deep tech with medtech, particularly in the GI field, marks a significant step forward in the evolution of healthcare technology. His work with Endiatx and the development of PillBot™ could pave the way for new, minimally invasive methods for diagnosing and treating GI conditions.
Don’t miss this one.
- Backstory of Endiatx
- The reason behind picking GI
- Challenges faced when starting Endiatx
- “We were astounded at how many people are having difficulty accessing a basic procedure like upper endoscopy”
- What were the technical challenges faced?
- How can a GI doc navigate PillBot™ inside the gut?
- What happens after FDA approval?
- “My hope is some day a GI is gonna call us up and say a PillBot™ procedure during a routine inspection found a early stomach cancer”
- Endiatx Funding?
- “It’s very important for founders to know that..”
- Future of GI and medtech